SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A. C. Boos, B. Hagl, A. Schlesinger, B. E. Halm, N. Ballenberger, M. Pinarci, V. Heinz, D. Kreilinger, B. D. Spielberger, L. F. Schimke-Marques, J. Sawalle-Belohradsky, B. H. Belohradsky, B. Przybilla, B. Schaub, A. Wollenberg, E. D. Renner, Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern, Allergy, 2015, 70, 9
  2. 2
    A. C. Boos, B. Hagl, A. Schlesinger, B. E. Halm, N. Ballenberger, M. Pinarci, V. Heinz, D. Kreilinger, B. D. Spielberger, L. F. Schimke-Marques, J. Sawalle-Belohradsky, B. H. Belohradsky, B. Przybilla, B. Schaub, A. Wollenberg, E. D. Renner, Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern, Allergy, 2015, 70, 9
  3. 3
    S. Weidinger, N. Novak, Atopic dermatitis revisited, Allergy, 2014, 69, 1
  4. You have free access to this content4
    M.R. Ardern-Jones, T. Bieber, Biomarkers in atopic dermatitis: it is time to stratify, British Journal of Dermatology, 2014, 171, 2
  5. You have free access to this content5
    A. Wollenberg, A. Seba, A.S. Antal, Immunological and molecular targets of atopic dermatitis treatment, British Journal of Dermatology, 2014, 170,
  6. 6
    D. Simon, T. Bieber, Systemic therapy for atopic dermatitis, Allergy, 2014, 69, 1
  7. 7
    A. Wollenberg, K. Feichtner, Atopic dermatitis and skin allergies – update and outlook, Allergy, 2013, 68, 12